NCT02171416View on ClinicalTrials.gov

Cold Contact Urticaria Treatment With Rilonacept

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

May 31, 2018

Conditions
Cold Contact Urticaria
Interventions
DRUG

Rilonacept

DRUG

Placebo

Trial Locations (2)

10117

University Berlin Charité ; Dermatology, Berlin

55131

Universitätsmedizin, Mainz

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT02171416 - Cold Contact Urticaria Treatment With Rilonacept | Biotech Hunter | Biotech Hunter